Development of multi-epitope peptide-based vaccines against SARS-CoV-2

Development of multi-epitope peptide-based vaccines against SARS-CoV-2

Extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated a pandemic involving so excess of 32 million infections and 980,031 deaths. Efficient vaccines are urgently wanted to stop SARS-CoV-2 infections. No vaccines have but been accepted for licensure by regulatory businesses. Although host immune responses to SARS-CoV-2 infections are starting to be unravelled, efficient clearance …

Development of multi-epitope peptide-based vaccines against SARS-CoV-2 Read More »